FierceBiotech ١ أبريل ٢٠٢٦ KBP hopes to revive troubled heart drug at center of deal fraud dispute with Novo Nordisk
FierceBiotech ٢٥ مارس ٢٠٢٦ Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China
FierceBiotech ١٢ مارس ٢٠٢٦ Novo Holdings sees assets shrink by a 3rd in wake of Novo Nordisk's nosediving share price
FierceBiotech ٢٥ فبراير ٢٠٢٦ Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess
FierceBiotech ٢٨ يناير ٢٠٢٦ With 200 JPM meetings, Novo Nordisk BD head searches for the next Metsera
FierceBiotech ٢١ يناير ٢٠٢٦ Novo Nordisk offloads diabetes assets to Aspect amid cell therapy retreat
FierceBiotech ١٥ يناير ٢٠٢٦ Novo Nordisk Foundation invests $860M in Danish institute nurturing homegrown biotechs
FierceBiotech ٢٥ نوفمبر ٢٠٢٥ <a href="https://www.fiercebiotech.com/pharma/novos-shares-tumble-8-after-2-trial-misses-semaglutide-alzheimers-disease" hreflang="en">Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease</a> #Alzheimer disease #Novo Nordisk